BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 4010678)

  • 21. A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities.
    Wilson JC; Yoon HS; Walker RJ; Eccles MR
    Nephrol Dial Transplant; 2007 May; 22(5):1338-46. PubMed ID: 17277342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical and pathological study of 47 cases with Alport syndrome].
    He X; Liu GL; Xia ZK; Ren XG; Gao YF; Fan ZM; Fu YF; Fu J; Gao CL; Mao S; Chen R
    Zhonghua Er Ke Za Zhi; 2008 Dec; 46(12):914-8. PubMed ID: 19134254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical and genetic features of the Alport 'syndromes'].
    Pescucci C; Longo I; Mari F; Scala E; Bruttini M; Caselli R; Renieri A
    G Ital Nefrol; 2005; 22(5):466-76. PubMed ID: 16267804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thin basement membrane nephropathy.
    Savige J; Rana K; Tonna S; Buzza M; Dagher H; Wang YY
    Kidney Int; 2003 Oct; 64(4):1169-78. PubMed ID: 12969134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody.
    Yoshioka K; Hino S; Takemura T; Maki S; Wieslander J; Takekoshi Y; Makino H; Kagawa M; Sado Y; Kashtan CE
    Am J Pathol; 1994 May; 144(5):986-96. PubMed ID: 8178947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benign familial hematuria due to mutation of the type IV collagen alpha4 gene.
    Lemmink HH; Nillesen WN; Mochizuki T; Schröder CH; Brunner HG; van Oost BA; Monnens LA; Smeets HJ
    J Clin Invest; 1996 Sep; 98(5):1114-8. PubMed ID: 8787673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alport's syndrome (progressive hereditary nephritis).
    Gaboardi F; Edefonti A; Imbasciati E; Tarantino A; Mihatsch MJ; Zollinger HU
    Clin Nephrol; 1974; 2(4):143-56. PubMed ID: 4603152
    [No Abstract]   [Full Text] [Related]  

  • 28. The glomerular basal lamina in hereditary nephritis.
    Yoshikawa N; Cameron AH; White RH
    J Pathol; 1981 Nov; 135(3):199-209. PubMed ID: 7320813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical and histopathological characteristics of biopsy-proven renal diseases in Croatia].
    Batinić D; Sćukanec-Spoljar M; Milosević D; Subat-Dezulović M; Saraga M; Delmis J; Puretić Z; Cvitkovic-Kuzmić A; Skitarelić N; Spajic M; Nizić L; Vrljicak K; Matković M; Kniewald H; Batinić D; Grković L; Borojević I; Flajsman S; Kosuljandić-Vukić D; Marić S; Ljubanović D
    Acta Med Croatica; 2007 Sep; 61(4):361-4. PubMed ID: 18044469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Segregation of hematuria in thin basement membrane disease with haplotypes at the loci for Alport syndrome.
    Buzza M; Wilson D; Savige J
    Kidney Int; 2001 May; 59(5):1670-6. PubMed ID: 11318937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome.
    Marcocci E; Uliana V; Bruttini M; Artuso R; Silengo MC; Zerial M; Bergesio F; Amoroso A; Savoldi S; Pennesi M; Giachino D; Rombolà G; Fogazzi GB; Rosatelli C; Martinhago CD; Carmellini M; Mancini R; Di Costanzo G; Longo I; Renieri A; Mari F
    Nephrol Dial Transplant; 2009 May; 24(5):1464-71. PubMed ID: 19129241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Living donor kidney transplantation from relatives with mild urinary abnormalities in Alport syndrome: long-term risk, benefit and outcome.
    Gross O; Weber M; Fries JW; Müller GA
    Nephrol Dial Transplant; 2009 May; 24(5):1626-30. PubMed ID: 19028755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Familial hematuric nephropathies].
    Gubler MC
    Rev Prat; 1997 Sep; 47(14):1545-9. PubMed ID: 9366112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of ocular manifestations in autosomal dominant Alport syndrome associated with haematological abnormalties.
    Colville D; Wang YY; Jamieson R; Collins F; Hood J; Savige J
    Ophthalmic Genet; 2000 Dec; 21(4):217-25. PubMed ID: 11135492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial hematuria: a clinical, ultrastructural and morphometric study.
    Schärer K; Waldherr R; Müller-Möhlis TC; Tariverdian G
    Prog Clin Biol Res; 1989; 305():173-7. PubMed ID: 2762351
    [No Abstract]   [Full Text] [Related]  

  • 36. The renal lesions of Alport syndrome.
    Heidet L; Gubler MC
    J Am Soc Nephrol; 2009 Jun; 20(6):1210-5. PubMed ID: 19470679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pathology of the kidney in the Alport syndrome.
    Spear GS
    Birth Defects Orig Artic Ser; 1974; 10(4):109-13. PubMed ID: 4470885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent familial hematuria in children and the locus for thin basement membrane nephropathy.
    Rana K; Wang YY; Powell H; Jones C; McCredie D; Buzza M; Udawela M; Savige J
    Pediatr Nephrol; 2005 Dec; 20(12):1729-37. PubMed ID: 16235097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benign familial hematuria.
    Yoshikawa N; Matsuyama S; Iijima K; Maehara K; Okada S; Matsuo T
    Arch Pathol Lab Med; 1988 Aug; 112(8):794-7. PubMed ID: 3395216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Recurrent hematuria in children].
    Dumas R; Baldet P; Bascoul S; Serres L; Jean R
    Arch Fr Pediatr; 1978; 35(7):737-55. PubMed ID: 736729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.